Intuitive Surgical (NASDAQ:ISRG) Given New $666.00 Price Target at Truist Financial

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by Truist Financial from $640.00 to $666.00 in a research report sent to investors on Friday,Benzinga reports. Truist Financial currently has a buy rating on the medical equipment provider’s stock.

A number of other equities research analysts also recently issued reports on the company. Royal Bank of Canada boosted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research boosted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday. Finally, Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $583.83.

Intuitive Surgical Price Performance

ISRG stock opened at $584.05 on Friday. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock’s fifty day moving average price is $546.03 and its 200-day moving average price is $503.38.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock valued at $22,070,807 in the last quarter. 0.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the third quarter worth $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.